ATENATIV

This brand name is authorized in Austria, Croatia, Estonia, Finland, France, Lithuania, Netherlands, Poland, Romania, Spain.

Active ingredients

The drug ATENATIV contains one active pharmaceutical ingredient (API):

1	Human plasma antithrombin III concentrate UNII T0LTO7L82X - ANTITHROMBIN III HUMAN
	Antithrombin III is a small glycoprotein anticoagulant that inactivates several enzymes of the coagulation system and accounts for most of the antithrombin activity in plasma. It is a member of the serpin superfamily.
	Read more about Antithrombin III

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ATENATIV Powder and solvent for solution for infusion	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B01AB02	Antithrombin III	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AB Heparin group
Discover more medicines within B01AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1800379, 1800380
ES	Centro de información online de medicamentos de la AEMPS	58301, 58544
FI	Lääkealan turvallisuus- ja kehittämiskeskus	389049, 389056
FR	Base de données publique des médicaments	69835497
HR	Agencija za lijekove i medicinske proizvode	HR-H-973250138
LT	Valstybinė vaistų kontrolės tarnyba	1089222, 1089223
NL	Z-Index G-Standaard	14018934, 14018950
NL	Z-Index G-Standaard, PRK	44881, 44911
PL	Rejestru Produktów Leczniczych	100195503
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66671001, W66671002